This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jul 8;351(2):190-2; author reply 190-2.

Ten years of alendronate treatment for osteoporosis in postmenopausal women

Salvatore L Ruggiero, Bhoomi Mehrotra

PMID: 15250063

Comment

Ten years of alendronate treatment for osteoporosis in postmenopausal women

Salvatore L Ruggiero et al. N Engl J Med. 2004.

. 2004 Jul 8;351(2):190-2; author reply 190-2.

Authors

Salvatore L Ruggiero, Bhoomi Mehrotra

PMID: 15250063

No abstract available

PubMed Disclaimer

Comment on

Ten years' experience with alendronate for osteoporosis in postmenopausal women.
Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA; Alendronate Phase III Osteoporosis Treatment Study Group. Bone HG, et al. N Engl J Med. 2004 Mar 18;350(12):1189-99. doi: 10.1056/NEJMoa030897. N Engl J Med. 2004. PMID: 15028823 Clinical Trial.

Similar articles

[Diphosphonate therapy and osteonecrosis of the jaw].
Løkken P, Skoglund LA, Skjelbred P. Løkken P, et al. Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7. Tidsskr Nor Laegeforen. 2007. PMID: 17700737 Review. Norwegian. No abstract available.
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J, Takeda T, Sato Y. Iwamoto J, et al. Curr Med Res Opin. 2006 May;22(5):919-28. doi: 10.1185/030079906X100276. Curr Med Res Opin. 2006. PMID: 16709313 Review.
Fosamax and osteonecrosis of the jaw--important questions and answers.
Wynn RL. Wynn RL. Gen Dent. 2008 May-Jun;56(4):315-7. Gen Dent. 2008. PMID: 19284187 No abstract available.
[Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R, Lamy O, Peytremann-Bridevaux I. Bize R, et al. Rev Med Suisse. 2008 Dec 10;4(183):2703. Rev Med Suisse. 2008. PMID: 19157286 French. No abstract available.
[Does alendronate reduce the risk of fractures in postmenopausal women with osteoporosis?].
Häuselmann HJ. Häuselmann HJ. Praxis (Bern 1994). 1997 Apr 9;86(15):613. Praxis (Bern 1994). 1997. PMID: 9213912 German. No abstract available.

See all similar articles

Cited by

Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.
Wan JT, Sheeley DM, Somerman MJ, Lee JS. Wan JT, et al. Bone Res. 2020 Mar 11;8:14. doi: 10.1038/s41413-020-0088-1. eCollection 2020. Bone Res. 2020. PMID: 32195012 Free PMC article. Review.
Osteonecrosis of the jaw associated with ziv-aflibercept.
Mawardi H, Enzinger P, McCleary N, Manon R, Villa A, Treister N, Woo SB. Mawardi H, et al. J Gastrointest Oncol. 2016 Dec;7(6):E81-E87. doi: 10.21037/jgo.2016.05.07. J Gastrointest Oncol. 2016. PMID: 28078129 Free PMC article.
Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw.
Son HJ, Kim JW, Kim SJ. Son HJ, et al. Maxillofac Plast Reconstr Surg. 2019 Jul 23;41(1):26. doi: 10.1186/s40902-019-0210-8. eCollection 2019 Dec. Maxillofac Plast Reconstr Surg. 2019. PMID: 31403036 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information